Self-Association of CIITA and Its Transactivation Potential

REFERENCES

• Accolla, R.. 1983. Human B cell variants immunoselected against a single Ia antigen subset have lost expression of several Ia antigen subsets. J. Exp. Med. 157:1053–1058.
   PubMed Web of Science ®Google Scholar
• Benedict, M. A., Y. Hu, N. Inohara, and G. Nunez. 2000. Expression and functional analysis of Apaf-1 isoforms. Extra Wd-40 repeat is required for cytochrome c binding and regulated activation of procaspase-9. J. Biol. Chem. 275:8461–8468.
   PubMedGoogle Scholar
• Bertin, J., W.-J. Nir, C. M. Fischer, O. V. Tayber, P. R. Errada, J. R. Grant, J. J. Keilty, M. L. Grosselin, K. E. Robison, G. H. W. Wong, M. A. Glucksmann, and P. S. DiStefano. 1999. Human CARDY protein is a novel CED-4/Adaf-1 cell death family member that activates NF-κB. J. Biol. Chem. 274:12955–12958.
   PubMed Web of Science ®Google Scholar
• Brown, J. A., E. M. Rogers, and J. M. Boss. 1998. The MHC class II transactivator (CIITA) requires conserved leucine charged domains for interactions with the conserved W box promoter element. Nucleic Acids Res. 26:4128–4136.
   PubMedGoogle Scholar
• Chang, C.-H., J. Fontes, M. Peterlin, and R. A. Flavell. 1994. Class II, transactivator (CIITA) is sufficient for the inducible expression of major histocompatibility complex class II genes. J. Exp. Med. 180:1367–1374.
   PubMedGoogle Scholar
• Chin, K. C., G. Li, and J. P. Ting. 1997. Activation and transdominant suppression of MHC class II and HLA-DMB promoters by a series of C-terminal class II transactivator deletion mutants. J. Immunol. 159:2789–2794.
   PubMedGoogle Scholar
• Chin, K.-C., G. G.-X. Li, and J. P.-Y. Ting. 1997. Importance of acidic, proline/serine/threonine-rich, and GTP-binding regions in the major histocompatibility complex class II transactivator: generation of transdominant-negative mutants. Proc. Natl. Acad. Sci. USA 94:2501–2506.
   PubMedGoogle Scholar
• Cressman, D. E., K. C. Chin, D. J. Taxman, and J. P. Ting. 1999. A defect in the nuclear translocation of CIITA causes a form of type II bare lymphocyte syndrome. Immunity 10:163–171.
   PubMed Web of Science ®Google Scholar
• dePreval, C., B. Lisowska-Grospierre, M. Loche, C. Griscelli, and B. Mach. 1985. A trans-acting class II regulatory gene unlinked to the MHC controls expression of HLA class II genes. Nature 318:291–293.
   PubMedGoogle Scholar
• DeSandro, A. M., U. M. Nagarajan, and J. M. Boss. 2000. Associations and interactions between bare lymphocyte syndrome factors. Mol. Cell. Biol. 20:6587–6599.
   PubMedGoogle Scholar
• Durand, B., M. Kobr, W. Reith, and B. Mach. 1994. Functional complementation of major histocompatibility complex class II regulatory mutants by the purified X-box-binding protein RFX. Mol. Cell. Biol. 14:6839–6847.
   PubMedGoogle Scholar
• Fontes, J. D., N. Jabrane-Ferrat, C. R. Toth, and B. M. Peterlin. 1996. Binding and cooperative interactions between two B-cell-specific transcriptional coactivators. J. Exp. Med. 183:2517–2521.
   PubMedGoogle Scholar
• Fontes, J. D., B. Jiang, and B. M. Peterlin. 1997. The class II trans-activator CIITA interacts with the TBP-associated factor TAFII32. Nucleic Acids Res. 25:2522–2528.
   PubMed Web of Science ®Google Scholar
• Fontes, J. D., S. Kanazawa, D. Jean, and B. M. Peterlin. 1999. Interactions between the class II transactivator and CREB binding protein increase transcription of major histocompatibility complex class II genes. Mol. Cell. Biol. 19:941–947.
   PubMedGoogle Scholar
• Gourley, T., S. Roys, N. W. Lukacs, S. L. Kunkel, R. A. Flavell, and C. H. Chang. 1999. A novel role for the major histocompatibility complex class II transactivator CIITA in the repression of IL-4 production. Immunity 10:377–386.
   PubMedGoogle Scholar
• Griscelli, C., B. Lisowska-Grospierre, and B. Mach. 1989. Combined immunodeficiency with defective expression in MHC class II genes. Immunodeficiency Rev. 1:135
   PubMedGoogle Scholar
• Hake, S. B., K. Masternak, C. Kammerbauer, C. Janzen, W. Reith, and V. Steimle. 2000. CIITA leucine-rich repeats control nuclear localization, in vivo recruitment to the major histocompatibility complex (MHC) class II enhanceosome, and MHC class II gene transactivation. Mol. Cell. Biol. 20:7716–7725.
   PubMedGoogle Scholar
• Harton, J. A., D. E. Cressman, K. C. Chin, C. J. Der, and J. P. Ting. 1999. GTP binding by class II transactivator: role in nuclear import. Science 285:1402–1405.
   PubMedGoogle Scholar
• Heery, D. M., T. Zacharewski, B. Pierrat, H. Gronemeyer, P. Chambon, and R. Losson. 1993. Efficient transactivation by retinoic acid receptors in yeast requires retinoid X receptors. Proc. Natl. Acad. Sci. USA 90:4281–4285.
   PubMedGoogle Scholar
• Inohara, N., T. Koseki, L. del Peso, Y. Hu, C. Yee, S. Chen, R. Carrio, J. Merino, D. Liu, J. Ni, and G. Nunez. 1999. Nod1, an Apaf-1-like activator of caspase-9 and nuclear factor-kappaB. J. Biol. Chem. 274:14560–14567.
   PubMed Web of Science ®Google Scholar
• Inohara, N., T. Koseki, J. Lin, L. del Peso, P. C. Lucas, F. F. Chen, Y. Ogura, and G. Nunez. 2000. An induced proximity model for NF-kappa B activation in the Nod1/RICK and RIP signaling pathways. J. Biol. Chem. 275:27823–27831.
   PubMed Web of Science ®Google Scholar
• Jabrane-Ferrat, N., and B. M. Peterlin. 1994. Ets-1 activates the DRA promoter in B cells. Mol. Cell. Biol. 14:7314–7321.
   PubMedGoogle Scholar
• Kajava, A. V.. 1998. Structural diversity of leucine-rich repeat proteins. J. Mol. Biol. 277:519–527.
   PubMed Web of Science ®Google Scholar
• Kretsovali, A., T. Agalioti, C. Spilianakis, E. Tzortzakaki, M. Merika, and J. Papamatheakis. 1998. Involvement of CREB binding protein in expression of major histocompatibility complex class II genes via interaction with the class II transactivator. Mol. Cell. Biol. 18:6777–6783.
   PubMed Web of Science ®Google Scholar
• Li, P., D. Nijhawan, I. Budihardjo, S. M. Srinivasula, M. Ahmad, E. S. Alnemri, and X. Wang. 1997. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91:479–489.
   PubMed Web of Science ®Google Scholar
• Linhoff, M. W., K. L. Wright, and J. P. Ting. 1997. CCAAT-binding factor NF-Y and RFX are required for in vivo assembly of a nucleoprotein complex that spans 250 base pairs: the invariant chain promoter as a model. Mol. Cell. Biol. 17:4589–4596.
   PubMedGoogle Scholar
• Linhoff, M. W., J. A. Harton, D. E. Cressman, B. K. Martin, and J. P. Ting. 2001. Two distinct domains within CIITA mediate self-association: involvement of the GTP-binding and leucine-rich repeat domains. Mol. Cell. Biol. 21:3001–3011.
   PubMedGoogle Scholar
• Louis-Plence, P., C. S. Moreno, and J. M. Boss. 1997. Formation of a regulatory factor X/X2 box-binding protein/nuclear factor-Y multiprotein complex on the conserved regulatory regions of HLA class II genes. J. Immunol. 159:3899–3909.
   PubMedGoogle Scholar
• Mach, B., V. Steimle, E. Martinez-Soria, and W. Reith. 1996. Regulation of MHC class II genes: lessons from a disease. Annu. Rev. Immunol. 14:301–331.
   PubMed Web of Science ®Google Scholar
• Masternak, K., A. Muhlethaler-Mottet, J. Villard, M. Zufferey, V. Steimle, and W. Reith. 2000. CIITA is a transcriptional coactivator that is recruited to MHC class II promoters by multiple synergistic interactions with an enhanceosome complex. Genes Dev. 14:1156–1166.
   PubMed Web of Science ®Google Scholar
• Mitts, M. R., D. B. Grant, and W. Heideman. 1990. Adenylate cyclase in Saccharomyces cerevisiae is a peripheral membrane protein. Mol. Cell. Biol. 10:3873–3883.
   PubMedGoogle Scholar
• Moreno, C. S., G. W. Beresford, P. Louis-Plence, A. C. Morris, and J. M. Boss. 1999. CREB regulates MHC class II expression in a CIITA-dependent manner. Immunity 10:143–151.
   PubMedGoogle Scholar
• Nolte, R. T., G. B. Wisely, S. Westin, J. E. Cobb, M. H. Lambert, R. Kurokawa, M. G. Rosenfeld, T. M. Willson, C. K. Glass, and M. V. Milburn. 1998. Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-gamma. Nature 395:137–143.
   PubMed Web of Science ®Google Scholar
• Reith, W., C.-A. Siegrist, B. Durand, E. Barras, and B. Mach. 1994. Function of major histocompatibility complex class II promoters requires cooperative binding between factors RFX and NF-Y. Proc. Natl. Acad. Sci. USA 91:554–558.
   PubMedGoogle Scholar
• Schneider, R., E. Schneider-Scherzer, M. Thurnher, B. Auer, and M. Schweiger. 1988. The primary structure of human ribonuclease/angiogenin inhibitor (RAI) discloses a novel highly diversified protein superfamily with a common repetitive module. EMBO J. 7:4151–4156.
   PubMedGoogle Scholar
• Scholl, T., S. K. Mahanta, and J. L. Strominger. 1997. Specific complex formation between the type II bare lymphocyte syndrome-associated transactivators CIITA and RFX5. Proc. Natl. Acad. Sci. USA 94:6330–6334.
   PubMedGoogle Scholar
• Sisk, T. J., T. Gourley, S. Roys, and C. H. Chang. 2000. MHC class II transactivator inhibits IL-4 gene transcription by competing with NF-AT to bind the coactivator CREB binding protein (CBP)/p300. J. Immunol. 165:2511–2517.
   PubMed Web of Science ®Google Scholar
• Spilianakis, C., J. Papamatheakis, and A. Kretsovali. 2000. Acetylation by PCAF enhances CIITA nuclear accumulation and transactivation of major hisocompatibility complex class II genes. Mol. Cell. Biol. 20:8489–8498.
   PubMed Web of Science ®Google Scholar
• Steimle, V., L. A. Otten, M. Zufferey, and B. Mach. 1993. Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome). Cell 75:135–146.
   PubMed Web of Science ®Google Scholar
• Steimle, V., C.-A. Siegrist, A. Mottet, B. Lisowska-Grospierre, and B. Mach. 1994. Regulation of MHC class II expression by interferon-γ-mediated by the transactivator gene CIITA. Science 265:106–109.
   PubMed Web of Science ®Google Scholar
• Villard, J., M. Peretti, K. Masternak, E. Barras, G. Caretti, R. Mantovani, and W. Reith. 2000. A functionally essential domain of RFX5 mediates activation of major histocompatibility complex class II promoters by promoting cooperative binding between RFX and NF-Y. Mol. Cell. Biol. 20:3364–3376.
   PubMedGoogle Scholar
• Wright, K. L., B. J. Vilen, Y. Itoh-Lindstrom, T. L. Moore, G. Li, M. Criscitiello, P. Cogswell, J. B. Clarke, and J. P. Ting. 1994. CCAAT box binding protein NF-Y facilitates in vivo recruitment of upstream DNA binding transcription factors. EMBO J. 13:4042–4053.
   PubMedGoogle Scholar
• Zhou, H., H. S. Su, X. Zhang, J. Douhan III, and L. H. Glimcher. 1997. CIITA-dependent and-independent class II MHC expression revealed by a dominant negative mutant. J. Immunol. 158:4741–4749.
   PubMed Web of Science ®Google Scholar
• Zhu, X. S., M. W. Linhoff, G. Li, K. C. Chin, S. N. Maity, and J. P. Ting. 2000. Transcriptional scaffold: CIITA interacts with NF-Y, RFX, and CREB to cause stereospecific regulation of the class II major histocompatibility complex promoter. Mol. Cell. Biol. 20:6051–6061.
   PubMed Web of Science ®Google Scholar
• Zou, H., W. J. Henzel, X. Liu, A. Lutschg, and X. Wang. 1997. Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell 90:405–413.
   PubMed Web of Science ®Google Scholar